hrp0089p2-p050 | Bone, Growth Plate & Mineral Metabolism P2 | ESPE2018

Osteoporosis-pseudoglioma Syndrome (OPPG): Improvement of Osteoporosis on Biphosphonate Therapy

Karakilic Ozturan Esin , Altunoglu Umut , Derya Kardelen Asli , Yavas Abali Zehra , Avci Sahin , Kayserili Karabey Hulya , Poyrazoglu Sukran , Bas Firdevs , Darendeliler Feyza

Background: Osteoporosis-pseudoglioma syndrome (OPPG), rare autosomal recessive entity, is characterized by juvenile osteoporosis, bone deformities, neuromotor retardation, and congenital blindness. This syndrome is due to the loss-of-function mutation in LRP5 (Low-density lipoprotein receptor-related protein 5). Here report four cases from three families, with confirmed molecular diagnosis who showed improvement of osteoporosis improved with biphosphonate therapy.<p class...